- Home
- AZ vs LFCR Comparison
AZ vs LFCR Comparison
Compare AZ & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZ
- LFCR
- Stock Information
- Founded
- AZ 2018
- LFCR 1986
- Country
- AZ Canada
- LFCR United States
- Employees
- AZ N/A
- LFCR N/A
- Industry
- AZ Industrial Machinery/Components
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- AZ Industrials
- LFCR Health Care
- Exchange
- AZ Nasdaq
- LFCR Nasdaq
- Market Cap
- AZ 319.5M
- LFCR 256.6M
- IPO Year
- AZ N/A
- LFCR N/A
- Fundamental
- Price
- AZ $5.38
- LFCR $7.63
- Analyst Decision
- AZ Strong Buy
- LFCR Buy
- Analyst Count
- AZ 1
- LFCR 4
- Target Price
- AZ $20.00
- LFCR $8.00
- AVG Volume (30 Days)
- AZ 359.0K
- LFCR 156.0K
- Earning Date
- AZ 11-13-2025
- LFCR 01-02-2026
- Dividend Yield
- AZ N/A
- LFCR N/A
- EPS Growth
- AZ N/A
- LFCR N/A
- EPS
- AZ N/A
- LFCR N/A
- Revenue
- AZ $6,962,000.00
- LFCR $128,867,000.00
- Revenue This Year
- AZ $1,343,857.60
- LFCR $4.72
- Revenue Next Year
- AZ N/A
- LFCR $10.97
- P/E Ratio
- AZ N/A
- LFCR N/A
- Revenue Growth
- AZ 20.51
- LFCR 0.47
- 52 Week Low
- AZ $5.00
- LFCR $4.76
- 52 Week High
- AZ $12.36
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- AZ 32.28
- LFCR 57.23
- Support Level
- AZ $5.02
- LFCR $7.74
- Resistance Level
- AZ $5.49
- LFCR $8.49
- Average True Range (ATR)
- AZ 0.46
- LFCR 0.40
- MACD
- AZ -0.06
- LFCR 0.10
- Stochastic Oscillator
- AZ 16.21
- LFCR 55.40
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.